433 related articles for article (PubMed ID: 29030243)
1. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia.
Réus GZ; Becker IRT; Scaini G; Petronilho F; Oses JP; Kaddurah-Daouk R; Ceretta LB; Zugno AI; Dal-Pizzol F; Quevedo J; Barichello T
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():55-63. PubMed ID: 29030243
[TBL] [Abstract][Full Text] [Related]
2. Ketamine potentiates oxidative stress and influences behavior and inflammation in response to lipolysaccharide (LPS) exposure in early life.
Réus GZ; Simões LR; Colpo GD; Scaini G; Oses JP; Generoso JS; Prossin AR; Kaddurah-Daouk R; Quevedo J; Barichello T
Neuroscience; 2017 Jun; 353():17-25. PubMed ID: 28433652
[TBL] [Abstract][Full Text] [Related]
3. Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.
da Silva Araújo T; Maia Chaves Filho AJ; Monte AS; Isabelle de Góis Queiroz A; Cordeiro RC; de Jesus Souza Machado M; de Freitas Lima R; Freitas de Lucena D; Maes M; Macêdo D
J Psychiatr Res; 2017 Jan; 84():49-58. PubMed ID: 27697587
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat.
Wang J; Li X; He S; Hu L; Guo J; Huang X; Hu J; Qi Y; Chen B; Shang D; Wen Y
J Ethnopharmacol; 2018 Mar; 214():13-21. PubMed ID: 29217494
[TBL] [Abstract][Full Text] [Related]
6. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.
Song P; Ramprasath T; Wang H; Zou MH
Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.
Duda W; Curzytek K; Kubera M; Connor TJ; Fagan EM; Basta-Kaim A; Trojan E; Papp M; Gruca P; Budziszewska B; Leśkiewicz M; Maes M; Lasoń W
Int Immunopharmacol; 2019 Aug; 73():527-538. PubMed ID: 31176083
[TBL] [Abstract][Full Text] [Related]
8. Ketamine Exhibits Different Neuroanatomical Profile After Mammalian Target of Rapamycin Inhibition in the Prefrontal Cortex: the Role of Inflammation and Oxidative Stress.
Abelaira HM; Réus GZ; Ignácio ZM; Dos Santos MAB; de Moura AB; Matos D; Demo JP; da Silva JBI; Danielski LG; Petronilho F; Carvalho AF; Quevedo J
Mol Neurobiol; 2017 Sep; 54(7):5335-5346. PubMed ID: 27590136
[TBL] [Abstract][Full Text] [Related]
9. Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences.
Sampaio LRL; Cysne Filho FMS; de Almeida JC; Diniz DDS; Patrocínio CFV; de Sousa CNS; Patrocínio MCA; Macêdo D; Vasconcelos SMM
Neuroscience; 2018 Mar; 373():72-81. PubMed ID: 29337238
[TBL] [Abstract][Full Text] [Related]
10. Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia.
Zugno AI; Pacheco FD; Budni J; de Oliveira MB; Canever L; Heylmann AS; Wessler PG; da Rosa Silveira F; Mastella GA; Gonçalves CL; Freitas KV; de Castro AA; Streck EL; Quevedo J
Metab Brain Dis; 2015 Aug; 30(4):1043-53. PubMed ID: 25920483
[TBL] [Abstract][Full Text] [Related]
11. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases.
Boros FA; Bohár Z; Vécsei L
Mutat Res Rev Mutat Res; 2018; 776():32-45. PubMed ID: 29807576
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.
da Silva Dias IC; Carabelli B; Ishii DK; de Morais H; de Carvalho MC; Rizzo de Souza LE; Zanata SM; Brandão ML; Cunha TM; Ferraz AC; Cunha JM; Zanoveli JM
Mol Neurobiol; 2016 Dec; 53(10):6997-7009. PubMed ID: 26671617
[TBL] [Abstract][Full Text] [Related]
14. Changes in behavioural parameters, oxidative stress and neurotrophins in the brain of adult offspring induced to an animal model of schizophrenia: The effects of FA deficient or FA supplemented diet during the neurodevelopmental phase.
Canever L; Freire TG; Mastella GA; Damázio L; Gomes S; Fachim I; Michels C; Carvalho G; Godói AK; Peterle BR; Gava FF; Valvassori SS; Budni J; Quevedo J; Zugno AI
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():52-64. PubMed ID: 29782958
[TBL] [Abstract][Full Text] [Related]
15. Major Developments in the Design of Inhibitors along the Kynurenine Pathway.
Jacobs KR; Castellano-Gonzalez G; Guillemin GJ; Lovejoy DB
Curr Med Chem; 2017; 24(23):2471-2495. PubMed ID: 28464785
[TBL] [Abstract][Full Text] [Related]
16. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?
Connor TJ; Starr N; O'Sullivan JB; Harkin A
Neurosci Lett; 2008 Aug; 441(1):29-34. PubMed ID: 18584961
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway.
Wang B; Lian YJ; Su WJ; Peng W; Dong X; Liu LL; Gong H; Zhang T; Jiang CL; Wang YX
Brain Behav Immun; 2018 Aug; 72():51-60. PubMed ID: 29195782
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.
Zugno AI; Chipindo HL; Volpato AM; Budni J; Steckert AV; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Mastella GA; Maravai SG; Wessler PG; Binatti AR; Panizzutti B; Schuck PF; Quevedo J; Gama CS
Neuroscience; 2014 Feb; 259():223-31. PubMed ID: 24316471
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.
Larkin PB; Sathyasaikumar KV; Notarangelo FM; Funakoshi H; Nakamura T; Schwarcz R; Muchowski PJ
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2345-2354. PubMed ID: 27392942
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR
J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
